Dellora Investments LP - 06 Nov 2024 Form 3 Insider Report for PIERIS PHARMACEUTICALS, INC. (PVLA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
18 Nov 2024, 16:16:52 UTC
Next SEC filing
16 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Dellora Investments LP, /s/ Kevin Pyun, Principal, Dellora Investments GP LLC, its General Partner

Key filing fact

Dellora Investments LP filed Form 3 for PIERIS PHARMACEUTICALS, INC. (PVLA) on 18 Nov 2024.

Key facts

  • This page summarizes Dellora Investments LP's Form 3 filing for PIERIS PHARMACEUTICALS, INC. (PVLA).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Nov 2024, 16:16.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PIRS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
141,079
Date
06 Nov 2024
Ownership
See Footnote
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting persons are Dellora Investments LP ("Dellora") and Mr. Kevin Pyun. Dellora is the investment adviser to private funds managed by Dellora that hold securities directly for the benefit of their investors. Dellora may be deemed to beneficially own such securities indirectly as the investment adviser of the private funds and Mr. Pyun may be deemed to beneficially own them indirectly as the control person of Dellora. Each of Dellora and Mr. Pyun disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .